Status:
COMPLETED
Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborating Sponsors:
Boston Children's Hospital
Society of Critical Care Medicine
Conditions:
Eye Injuries
Critically Ill
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
The purpose of this study is to identify the incidence of scratches on the surface of the eye in children who cannot blink due to medication use and to identify how best to reduce the risk of a scratc...
Detailed Description
Critically ill children may require neuromuscular blockade as a treatment modality. These children require careful eye care to prevent corneal abrasions. However, current evidence does not exist to gu...
Eligibility Criteria
Inclusion
- Age greater than 42 weeks post-conceptual age and less than 18 years
- Anticipated need for neuromuscular blockade therapy for at least 24 hours
Exclusion
- Use of continuous neuromuscular blockade therapy for more than 36 hours (early intervention study)
- Past medical history of abnormal blink reflex or incomplete lid closure
- History of daily eye drop use
- Facial trauma
- Alteration in periorbital skin integrity prohibiting eyelid closure or effective creation of a moisture chamber
- Known allergy to eye lubricant
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00129077
Start Date
March 1 2004
End Date
December 1 2006
Last Update
July 10 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Memorial Hospital
Chicago, Illinois, United States, 60614
2
Children's Hospital Boston
Boston, Massachusetts, United States, 02115